Patients with osteoporosis exhibit a nearly twofold higher diagnosis rate of periodontitis compared to the general population, indicating osteoporosis is a potentially significant risk factor for periodontitis development. This study explored changes in periodontal and radiological parameters after systemic alendronate use in osteoporotic patients with periodontal disease. Sixty-four post-menopausal adults diagnosed with osteoporosis and periodontal disease were divided into two groups: Group A, without bisphosphonate therapy, and Group B, receiving alendronate (70mg/week) for 12 months. Both groups underwent non-surgical periodontal treatment. Parameters including plaque index (PI), bleeding on probing (BOP), probing depth (PD), clinical attachment loss (CAL), and radiographic infrabony defect depth (IBD) were evaluated at baseline and after 12 months. Oral administration of alendronate at 70 mg/week for 12 months was found to be safe and effective in enhancing the outcomes of non-surgical periodontal therapy both clinically and radiologically. This suggests alendronate could be a valuable adjunctive treatment for managing periodontal disease in osteoporotic patients
15 March 2024 in Romanian Journal of Oral Rehabilitation
At the beginning of the COVID-19 outbreak, children appeared to be less susceptible to SARS-CoV-2 infection than adults or more prone to develop asymptomatic and mild forms of the disease, which could have led to an underestimation of epidemiological data in young patients. Age-related differences in viral receptor expression, immune system competence, and comorbidity rates partially explained the lower prevalence of COVID-19 infection in pediatric patients. However, especially after the spread of the Omicron virus variant and due to the relaxation of social and health measures, the number of young people infected with SARS-CoV-2 has increased. The aim of the conducted study was to investigate periodontal clinical parameters, represented by plaque index, probing bleeding index and clinical periodontal attachment loss in pediatric patients, along with a series of demographic parameters, in the post-SARS-CoV-2 infection period. Conclusions: Our study provided evidence of widespread declines in periodontal health status and access to oral health care among children post-SARS-CoV-2 infection. Subjects with a lower amount of plaque showed a high intensity of periodontal inflammation, negatively correlated with time since diagnosis, a fact that supports the influence of the cytokine storm released post-SARS-CoV-2 infection and at the periodontal level.
15 September 2024 in Romanian Journal of Oral Rehabilitation
This study investigates the potential link between periodontitis and the development of hypertension, aiming to assess the risk of hypertension in individuals with periodontal disease. Periodontitis, a chronic inflammatory condition affecting the supporting structures of teeth, has been increasingly associated with systemic health issues, including cardiovascular diseases. We conducted a comprehensive review of existing literature and analyzed data from clinical studies to evaluate the prevalence and severity of hypertension in patients with periodontitis. Our findings suggest a significant correlation between periodontal inflammation and elevated blood pressure, highlighting the role of systemic inflammation as a contributing factor. The study emphasizes the importance of early diagnosis and management of periodontitis as a potential strategy to mitigate the risk of hypertension. Further research is recommended to explore the underlying mechanisms and to develop integrated approaches for the prevention and treatment of both conditions. This investigation underscores the need for interdisciplinary collaboration between dental and medical professionals to enhance patient care and outcomes.